Skip to main content
Clinical Trials/JPRN-UMIN000049408
JPRN-UMIN000049408
Completed
未知

Effects of combined SGLT2 inhibitor and DPP-4 inhibitor therapy on advanced glycation end products - Effects of combined SGLT2 inhibitor and DPP-4 inhibitor therapy on advanced glycation end products

Akishima Clinic0 sites35 target enrollmentNovember 2, 2022
ConditionsType 2 diabetes

Overview

Phase
未知
Intervention
Not specified
Conditions
Type 2 diabetes
Sponsor
Akishima Clinic
Enrollment
35
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 2, 2022
End Date
July 7, 2022
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Akishima Clinic

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • eGFR: less than 45 mL/min/1\.73 m2

Outcomes

Primary Outcomes

Not specified

Similar Trials